A Genetic Polymorphism in TOX3 is Associated with Survival of Gastric Cancer in a Chinese Population.
Xiaojing Zhang,Haixia Zhu,Xiaomin Wu,Meilin Wang,Dongying Gu,Weida Gong,Zhi Xu,Yongfei Tan,Yongling Gong,Jianwei Zhou,Cuiju Tang,Na Tong,Jinfei Chen,Zhengdong Zhang
DOI: https://doi.org/10.1371/journal.pone.0072186
IF: 3.7
2013-01-01
PLoS ONE
Abstract:Purpose: Recently, genetic polymorphism (rs3803662C>T) in TOX3 was reported to induce the risk of breast cancer. In this study, we hypothesized that rs3803662 could influence gastric cancer survival outcomes.Methods: With multiplex SNaPshot method, we genotyped TOX3 rs3803662 in 880 gastric patients with surgical resection. The association between genotype and survival outcomes was performed by the Kaplan-Meier method, Cox regression analysis models and the log-rank test.Results: There was no association in the analyses of rs3803662 and survival of gastric cancer. However, the stratified analysis by histology showed that rs3803662 CT/TT genotype was associated with a significantly better survival for diffuse-type gastric cancer (log-rank p = 0.030, hazard ratio [HR] = 0.67, 95% confidence interval [CI] = 0.46-0.96), than the CC genotype. In addition, this favorable effect was especially obvious among gastric cancer patients with tumor size >5 cm, T3 and T4 depth of invasion, lymph node metastasis, no drinking, no distant metastasis, no chemotherapy and gastric cardia cancer.Conclusions: TOX3 rs3803662 might play an important role in the prognostic outcome and treatment of gastric cancer, especially perhaps further help in explaining the reduced risk of death associated with diffuse-type gastric cancer.